Tianjin Ringpu Bio-Technology Co.,Ltd. (300119.SZ)
CNY 18.81
(9.49%)
CNY 18.81
(9.49%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.11 Billion CNY | 10.68% |
| 2022 | 1 Billion CNY | -2.9% |
| 2021 | 1.03 Billion CNY | -3.82% |
| 2020 | 1.08 Billion CNY | 40.86% |
| 2019 | 767.42 Million CNY | 28.7% |
| 2018 | 596.27 Million CNY | 7.39% |
| 2017 | 555.23 Million CNY | -0.18% |
| 2016 | 556.24 Million CNY | 19.46% |
| 2015 | 465.64 Million CNY | 33.77% |
| 2014 | 348.08 Million CNY | -22.31% |
| 2013 | 448.02 Million CNY | 16.94% |
| 2012 | 383.13 Million CNY | 17.06% |
| 2011 | 327.28 Million CNY | 33.66% |
| 2010 | 244.86 Million CNY | 11.03% |
| 2009 | 220.53 Million CNY | 33.56% |
| 2008 | 165.11 Million CNY | 67.41% |
| 2007 | 98.63 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 329.55 Million CNY | 30.46% |
| 2024 Q1 | 254.47 Million CNY | -17.6% |
| 2024 Q2 | 252.61 Million CNY | -0.73% |
| 2023 Q4 | 308.82 Million CNY | 5.79% |
| 2023 FY | 1.11 Billion CNY | 10.68% |
| 2023 Q1 | 225.7 Million CNY | -26.01% |
| 2023 Q2 | 291 Million CNY | 28.93% |
| 2023 Q3 | 291.91 Million CNY | 0.31% |
| 2022 FY | 1 Billion CNY | -2.9% |
| 2022 Q4 | 305.03 Million CNY | 15.1% |
| 2022 Q3 | 265 Million CNY | 7.49% |
| 2022 Q2 | 246.54 Million CNY | 27.7% |
| 2022 Q1 | 193.05 Million CNY | -25.25% |
| 2021 Q3 | 230.65 Million CNY | -9.66% |
| 2021 Q4 | 258.26 Million CNY | 11.97% |
| 2021 Q2 | 255.31 Million CNY | -13.61% |
| 2021 FY | 1.03 Billion CNY | -3.82% |
| 2021 Q1 | 295.52 Million CNY | 14.45% |
| 2020 Q4 | 258.21 Million CNY | -14.28% |
| 2020 FY | 1.08 Billion CNY | 40.86% |
| 2020 Q1 | 258.55 Million CNY | 10.89% |
| 2020 Q2 | 263.01 Million CNY | 1.73% |
| 2020 Q3 | 301.23 Million CNY | 14.53% |
| 2019 Q1 | 154.32 Million CNY | -9.1% |
| 2019 Q4 | 233.16 Million CNY | 13.88% |
| 2019 FY | 767.42 Million CNY | 28.7% |
| 2019 Q3 | 204.74 Million CNY | 16.87% |
| 2019 Q2 | 175.18 Million CNY | 13.52% |
| 2018 Q3 | 144.53 Million CNY | 1.78% |
| 2018 FY | 596.27 Million CNY | 7.39% |
| 2018 Q1 | 139.95 Million CNY | -9.63% |
| 2018 Q2 | 142.01 Million CNY | 1.47% |
| 2018 Q4 | 169.77 Million CNY | 17.47% |
| 2017 Q4 | 154.86 Million CNY | 10.0% |
| 2017 FY | 555.23 Million CNY | -0.18% |
| 2017 Q1 | 127.09 Million CNY | -19.96% |
| 2017 Q2 | 132.49 Million CNY | 4.24% |
| 2017 Q3 | 140.78 Million CNY | 6.26% |
| 2016 FY | 556.24 Million CNY | 19.46% |
| 2016 Q4 | 158.8 Million CNY | 5.58% |
| 2016 Q3 | 150.41 Million CNY | 11.2% |
| 2016 Q2 | 135.26 Million CNY | 21.03% |
| 2016 Q1 | 111.76 Million CNY | -21.0% |
| 2015 Q2 | 95.93 Million CNY | -8.06% |
| 2015 FY | 465.64 Million CNY | 33.77% |
| 2015 Q3 | 123.89 Million CNY | 29.14% |
| 2015 Q4 | 141.46 Million CNY | 14.18% |
| 2015 Q1 | 104.34 Million CNY | 33.18% |
| 2014 Q1 | 76.63 Million CNY | -41.23% |
| 2014 FY | 348.08 Million CNY | -22.31% |
| 2014 Q3 | 101.28 Million CNY | 10.32% |
| 2014 Q2 | 91.81 Million CNY | 19.8% |
| 2014 Q4 | 78.34 Million CNY | -22.65% |
| 2013 FY | 448.02 Million CNY | 16.94% |
| 2013 Q1 | 94.13 Million CNY | -18.57% |
| 2013 Q3 | 105.26 Million CNY | -10.97% |
| 2013 Q4 | 130.39 Million CNY | 23.87% |
| 2013 Q2 | 118.23 Million CNY | 25.6% |
| 2012 FY | 383.13 Million CNY | 17.06% |
| 2012 Q1 | 80.9 Million CNY | -2.49% |
| 2012 Q2 | 98.89 Million CNY | 22.23% |
| 2012 Q3 | 87.72 Million CNY | -11.3% |
| 2012 Q4 | 115.59 Million CNY | 31.77% |
| 2011 Q2 | 78.28 Million CNY | 5.42% |
| 2011 Q4 | 82.97 Million CNY | -9.59% |
| 2011 Q1 | 74.26 Million CNY | 10.95% |
| 2011 FY | 327.28 Million CNY | 33.66% |
| 2011 Q3 | 91.76 Million CNY | 17.23% |
| 2010 Q1 | 62.97 Million CNY | 1.81% |
| 2010 FY | 244.86 Million CNY | 11.03% |
| 2010 Q4 | 66.93 Million CNY | 9.55% |
| 2010 Q3 | 61.09 Million CNY | 13.43% |
| 2010 Q2 | 53.86 Million CNY | -14.47% |
| 2009 FY | 220.53 Million CNY | 33.56% |
| 2009 Q3 | 57.7 Million CNY | 0.0% |
| 2009 Q4 | 61.85 Million CNY | 7.19% |
| 2008 FY | 165.11 Million CNY | 67.41% |
| 2007 FY | 98.63 Million CNY | 0.0% |